Home/Hedge Fund Intelligence/Catalyst Pharmaceuticals Inc
CPRXStockForm 13F30 Jun 2026

Hedge funds that hold Catalyst Pharmaceuticals Inc CPRX

CUSIP 14888U101 · who reports it, how much, and how much it matters to them

29 of the 720 hedge fund managers we track reported shares of Catalyst Pharmaceuticals Inc (CPRX) on Form 13F for 30 June 2026. Between them they reported USD 346m. The largest position belongs to HBK Investments, at USD 89m. The manager with the most riding on it is Versor Investments, where it is 5.0% of the reported book.

Managers reporting it29of 720 we track
Value they reportUSD 346mshares only, 30 Jun 2026
Funds they run321with a file on PPLI.com
Largest positionUSD 89mHBK Investments
Typical weight0.0%median share of a manager's book
Heaviest weight5.0%Versor Investments

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

29 managers, USD 346m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Catalyst Pharmaceuticals Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1HBK Investments7 funds on PPLI.comUSD 89m0.9%
2Renaissance Technologies13 funds on PPLI.comUSD 67m0.1%
3Polar Asset Management Partners6 funds on PPLI.comUSD 36m0.6%
4Millennium Management6 funds on PPLI.comUSD 34m0.0%
5Water Island Capital1 fund on PPLI.comUSD 29m2.7%
6Marshall Wace LLP84 funds on PPLI.comUSD 29m0.0%
7JW Asset Management5 funds on PPLI.comUSD 12m3.8%
8Melqart Asset Management (UK)3 funds on PPLI.comUSD 7.8m0.7%
9POINT72 Asset Management17 funds on PPLI.comUSD 5.5m0.0%
10Gabelli & Company Investment Advisers17 funds on PPLI.comUSD 5m0.7%
11D. E. Shaw & Co.15 funds on PPLI.comUSD 4.2m0.0%
12Schonfeld Strategic Advisors30 funds on PPLI.comUSD 4m0.0%
13Kintayl Capital2 funds on PPLI.comUSD 3.6m1.4%
14Engineers Gate Manager1 fund on PPLI.comUSD 2.8m0.0%
15Citadel Advisors32 funds on PPLI.comUSD 2.7m0.0%
16LMR Partners2 funds on PPLI.comUSD 2.4m0.0%
17Versor Investments8 funds on PPLI.comUSD 2.4m5.0%
18Wolverine Asset Management1 fund on PPLI.comUSD 2.3m0.0%
19Oxford Asset Management LLP2 funds on PPLI.comUSD 2.2m1.1%
20Prelude Capital Management9 funds on PPLI.comUSD 1.7m0.1%
21Diametric Capital2 funds on PPLI.comUSD 1.2m0.1%
22Two Sigma Investments35 funds on PPLI.comUSD 954,0000.0%
23Gamco Asset Management1 fund on PPLI.comUSD 440,0000.0%
24Squarepoint Ops7 funds on PPLI.comUSD 369,0000.0%
25Boothbay Fund Management2 funds on PPLI.comUSD 305,0000.0%
26Armistice Capital1 fund on PPLI.comUSD 212,0000.0%
27Neo Ivy Capital Management1 fund on PPLI.comUSD 106,0000.0%
28Persistent Asset Partners10 funds on PPLI.comUSD 73,2630.0%
29The Quarry1 fund on PPLI.comUSD 2,9860.0%
Next: where it matters most
Where it matters most

For Versor Investments it is 5.0% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Versor InvestmentsUSD 2.4m5.0%
2JW Asset ManagementUSD 12m3.8%
3Water Island CapitalUSD 29m2.7%
4Kintayl CapitalUSD 3.6m1.4%
5Oxford Asset Management LLPUSD 2.2m1.1%
6HBK InvestmentsUSD 89m0.9%
7Melqart Asset Management (UK)USD 7.8m0.7%
8Gabelli & Company Investment AdvisersUSD 5m0.7%
9Polar Asset Management PartnersUSD 36m0.6%
10Diametric CapitalUSD 1.2m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Catalyst Pharmaceuticals Inc

What is the ticker symbol of Catalyst Pharmaceuticals Inc?

Catalyst Pharmaceuticals Inc trades under the symbol CPRX. Its CUSIP, the code used on Form 13F, is 14888U101.

Which hedge funds own Catalyst Pharmaceuticals Inc (CPRX)?

29 of the 720 hedge fund managers PPLI.com tracks reported Catalyst Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by HBK Investments (USD 89m), Renaissance Technologies (USD 67m), Polar Asset Management Partners (USD 36m), Millennium Management (USD 34m) and Water Island Capital (USD 29m).

How many hedge funds hold Catalyst Pharmaceuticals Inc?

29 managers in our coverage reported it, and between them they run 321 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Catalyst Pharmaceuticals Inc?

Versor Investments, where the position was 5.0% of the reported 13F book at 30 June 2026.

Does this show who is short Catalyst Pharmaceuticals Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Catalyst Pharmaceuticals Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.